Cargando…
Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests
Many decisions in medicine involve trade-offs, such as between diagnosing patients with disease versus unnecessary additional testing for those who are healthy. Net benefit is an increasingly reported decision analytic measure that puts benefits and harms on the same scale. This is achieved by speci...
Autores principales: | Vickers, Andrew J, Van Calster, Ben, Steyerberg, Ewout W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724785/ https://www.ncbi.nlm.nih.gov/pubmed/26810254 http://dx.doi.org/10.1136/bmj.i6 |
Ejemplares similares
-
Decision curve analysis: confidence intervals and hypothesis testing for net benefit
por: Vickers, Andrew J., et al.
Publicado: (2023) -
A simple, step-by-step guide to interpreting decision curve analysis
por: Vickers, Andrew J., et al.
Publicado: (2019) -
There is no such thing as a validated prediction model
por: Van Calster, Ben, et al.
Publicado: (2023) -
Predictive analytics in health care: how can we know it works?
por: Van Calster, Ben, et al.
Publicado: (2019) -
Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers
por: Vickers, Andrew J, et al.
Publicado: (2008)